Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats
Gilles Pomier‐Layrargues, Lise Giroux, Bernard Rocheleau, Pierre‐Michel Huet – 1 May 1992 – We recently reported that ritanserin, a 5‐hydroxytryptamine receptor antagonist, induced significant reduction of portal pressure in cirrhotic rats. In this study, we investigated the hemodynamic effects of a combination of propranolol and ritanserin in conscious and unrestrained cirrhotic rats. Heparinized catheters exiting from the neck were placed into the portal vein, inferior vena cava, aorta and left ventricle.